India  /  Published 03.01.21

Covaxin jumps direct evidence

India’s drug regulatory expert panel on Saturday recommended conditional and restricted emergency use of a home-grown vaccine against the coronavirus disease without direct evidence for its prot...
By G.S. Mudur in New Delhi

India  /  Published 02.01.21

Homegrown Covaxin gets nod

Covaxin, the anti-coronavirus vaccine developed indigenously by India’s Hyderabad-based Bharat Biotech, has received restricted emergency use permission, with certain conditions, from an expert ...
By Our Bureau and Agencies in New Delhi

India  /  Published 01.01.21

Oxford vaccine emergency use

An expert panel on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended grant of permission for restricted emergency use of Oxford Covid-19 vaccine Covishield in I...
By Payal Banerjee in New Delhi

India  /  Published 29.12.20

Covaxin can take on mutated coronavirus

Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krish...
By Our Bureau and Agencies in Hyderabad

India  /  Published 24.12.20

Covaxin trials offer long-term immunity hope

India’s homegrown candidate vaccine against the novel coronavirus disease developed by the Hyderabad-based Bharat Biotech has generated a dual immune response that has raised hopes of immunity l...
By G.S. Mudur in New Delhi



Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.